Amarin Pharma Inc. NDCs and Package Codes
This page lists NDC package records associated with labeler code 52937 (Amarin Pharma Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
5
Package NDCs
4
Products
4
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
2
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 4 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| Vascepa icosapent ethyl 1000 mg/1 CAPSULE | 52937-0001-04 | — | Discontinued | View → |
| Vascepa icosapent ethyl 500 mg/1 CAPSULE | 52937-0003-16 | — | On market | View → |
| Vascepa icosapent ethyl 1000 mg/1 CAPSULE | 52937-0005-20 | — | On market | View → |
| Vascepa icosapent ethyl 1000 mg/1 CAPSULE | 52937-0101-08 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.